Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
drugs
fda
life sciences
national blog main
paul matteis
2
×
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
biotech
clinical trials
crispr
cystic fibrosis
cystic fibrosis foundation
gilead sciences
givosiran
hepatitis c
incivek
jeff leiden
kayldeco
matt emmens
messenger rna therapeutics
national top stories
onpattro
orkambi
patisiran
people
rna interference
sickle cell disease
stifel
stifel financial
symdeko
vertex pharmaceuticals
What
pharmaceuticals
2
×
ago
alnylam
approval
cf
crisis
cystic
developer
drug
fda
fibrosis
force
helped
indicated
interference
jeff
leiden
medicine
medicines
nod
profitable
quick
rna
rnai
roles
second
seek
shaped
speedy
steer
step
switch
vertex
weeks
won’t
Language
unknown
Current search:
pharmaceuticals
×
" paul matteis "
×
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
